Bill
H 1245
Overview: H 1245, "An Act to address barriers to HIV prevention medication", has a hearing scheduled for September 17, 2025 from 12:30 PM to 4:30 PM in the Gardner Auditorium. The
Overview: H 1245, "An Act to address barriers to HIV prevention medication", has a hearing scheduled for September 17, 2025 from 12:30 PM to 4:30 PM in the Gardner Auditorium. The bill was introduced on February 27, 2025.
Purpose and Intent: The main goal of this bill is to improve access to HIV prevention medication, such as pre-exposure prophylaxis (PrEP), by addressing barriers that prevent individuals from obtaining and using these medications.
Key Provisions:
- Requires health insurance plans to cover the full cost of HIV prevention medication without any cost-sharing for the patient
- Directs the state Medicaid program to cover HIV prevention medication without any cost-sharing
- Establishes a grant program to provide financial assistance to individuals who cannot afford HIV prevention medication
Affected Parties and Impacts: The bill would primarily benefit individuals at risk of contracting HIV, as it would make HIV prevention medication more accessible and affordable. It would also impact health insurance providers and the state Medicaid program, which would be required to cover the full cost of these medications.
Procedural and Timeline Considerations: The bill is currently scheduled for a public hearing on September 17, 2025. After the hearing, the committee will likely vote on whether to recommend the bill for further consideration by the full legislature.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
